Bronchodilating effects of cumulative doses of formoterol from a novel multi-dose inhaler (Airmax®)

Received 20 December 2001; accepted 17 May 2002.

Abstract

The bronchodilating properties of formoterol from a novel multi-dose inhaler, Airmax® 6μg and from a single-dose dry powder inhaler Foradil® Aeroliser® 12μg were investigated in 31 adult asthmatics with FEV1≥60% predicted and a reversibility ≥12%. Patients received on a single day four doses of formoterol: cumulative dose 6, 12, 24 and 48μg from Airmax, or 12, 24, 48 and 96μg from Aeroliser®. The mean FEV1 (SD) from baseline to 1h after the final cumulative dose increased by 0.81l from 2.62 (0.58) to 3.43l (0.70) with Airmax® and by 0.85l from 2.65 (0.60) to 3.5l (0.68) with Aeroliser®. All 90% CIs for all four dose comparisons were within the equivalence range ±0.1l. There was a higher incidence of hypokalaemia and hyperglycaemia at highest doses during treatment with the Aeroliser® than with Airmax®. In conclusion, formoterol delivered from Airmax® provides a dose-dependent bronchodilating effect which is similar to that obtained by Aeroliser® at double the dose.

Keywords: dry powder inhaler, multi-dose inhaler, single-dose inhaler, formoterol, long-acting β2-agonists, asthma, cumulative doses.

No full text is available. To read the body of this article, please view the PDF online.

Article Outline

• Abstract

• References

• Copyright

References

REFERENCES

1. 1 Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroids in asthma patients with symptoms on existing inhaled corticosteroids. Lancet. 1994;344:219–224. Abstract | CrossRef

2. 2 Pauwels RA, Löfdahl CG, Postma DS. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med. 1998;337:15 405–15 411.

3. 3 Juniper EF, Svensson K, O'Byrne PM. Asthma quality of life during one year of treatment with budesonide with or without formoterol. Eur Respir J. 1999;14:1038–1043. MEDLINE | CrossRef

4. 4 Derom EY, Pauwels RA. Time course of bronchodilating effect of inhaled formoterol, a potent and long-acting sympathomimetic. Thorax. 1992;47:30–33. MEDLINE | CrossRef

5. 5 Wallin A, Sandstrom T, Rosenhall L, Melander B. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma. Thorax. 1993;48:611–614. MEDLINE | CrossRef

6. 6 Zeng XM, O'Leary D, Phelan M, Jones S, Colledge J. Delivery of salbutamol and of budesonide from a novel multi dose inhaler Airmax®. Respir Med. 2002;96:404–411. Abstract | Full-Text PDF (183 KB) | CrossRef

7. 7 Zeng XM, Jones S, O'Leary D, Phelan M, Colledge J. Delivery of formoterol from a novel multi dose inhaler Airmax®. Respir Med. 2002;96:397–403. Abstract | Full-Text PDF (352 KB) | CrossRef

8. 8 Chew NY, Chan HK. In vitro aerosol performance and dose uniformity between the Foradil Aerolizer and the Oxis Turbuhaler. J Aerosol med. 2001;14:495–501. MEDLINE | CrossRef

9. 9 Maesen F PV, Costongs R, Smeets SJ, Zweers P GMA, Goedhart DM. Formoterol as dry powder inhalation; a dose finding study in comparison with formoterol metered dose inhaler and placebo. Chest. 1992;101:1376–1381. MEDLINE | CrossRef

10. 10 Ringdal N, Derom E, Wahlin-Boll E, Pauwels R. Onset and duration of action of single doses of formoterol inhaled via Turbuhaler®. Respir Med. 1998;92:1017–1021. Abstract | Full-Text PDF (502 KB) | CrossRef

11. 11 Shenfield G, Paterson J. Clinical assessment of bronchodilator drugs delivered by aerosol. Thorax. 1973;28:124. MEDLINE | CrossRef

12. 12 Duncan D, Paterson I, Harris D, Crompton G. Comparison of the effects of salbutamol inhaled as a dry powder and by conventional pressurized aerosol. Br J Clin Pharmacol. 1977;4:669–671.

13. 13 Foucard T, Lönnerholm G. A study with cumulative doses of formoterol and salbutamol in children with asthma. Eur Respir J. 1991;4:1174–1177. MEDLINE

14. 14 Palmqvist M, Persson G, Lazer L, Rosenborg J, Larsson P, Lotvall J. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency. Eur Resp J. 1997;10:2484–2489.

15. 15 Wallin A, Sandstrom T, Rosenhall L, Melander B. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma. Thorax. 1993;48:611–614. MEDLINE | CrossRef

a Reinier de Graaf Groep, Delft-Voorburg, The Netherlands

b Volendam, The Netherlands

f1 Correspondence should be addressed to: Dr. E. F. L. Dubois, Reinier de Graaf Groep, Delft-Voorburg, Fonteynenburglaan 5, P.O. Box 998, 2270 AZ Voorburg, The Netherlands. E-mail: dubois@rdgg.nl

PII: S0954-6111(02)91410-1

doi:10.1053/rmed.2002.1410

12 of 18